A clinical study on efficacy and safety of an Ayurvedic Formulation Kutajavaleha in the management of Grahani Roga.

Central Council for Research in Ayurvedic Sciences New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1.Known cases of Grahani roga (diagnostic criteria as per classical Ayurvedic Parameters)
•2. Patient willing to give written informed consent for participation in the study.

•1.Patients with history of Inflammatory bowel diseases (IBD), Abdominal Koch,Gluten Intolerance.
•2.Patients with history of Chronic amoebiasis.
•3.Known cases of Diabetes mellitus.
•4.Patients with poorly controlled Hypertension ( >160/100 mmHg).
•5.Patients who have history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
•6.Symptomatic patients with clinical evidence of Heart failure.
•7.Known cases of malignancy.
•8.Patients with concurrent serious hepatic disorders (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL), Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease (COPD).
•9.Women who are planning for conception / pregnant or lactating.
•10.H/o hypersensitivity to any of the trial drugs or their ingredients
•11. Patients who have completed participation in any other clinical trial during the past three months.
•12.Any other condition which the Investigator thinks may jeopardize the study.

发起方

Central Council for Research in Ayurvedic Sciences New Delhi